|
|
||||||||


*
Arthur and Sonia Labatt Brain Tumor Research Center and
Program in Developmental Biology, Hospital for Sick Children, Toronto, Ontario, Canada
| Abstract |
|---|
|
|
|---|

/
or CD4/CD8 T cell fate
specification. | Introduction |
|---|
|
|
|---|

TCR along with either CD4 or CD8
coreceptors, whereas a small population of mature T cells bears the

TCR. 
T cells develop in the thymus from
CD4-CD8-
(double-negative, DN)4
cells through an immature
CD4+CD8+ (double-positive,
DP) stage into mature CD4+ or
CD8+ (single-positive, SP) cells. Thymocytes
commit to the 
vs 
lineages very early in T cell
development at the
CD44-CD25- DN (DN4) stage
(1). Signals emanating from the pre-TCR and 
TCR
play well-defined roles in 
T cell development at the DN-DP and
DP-SP transitions, respectively.
Members of the Notch family play critical roles in the determination of
cell fate and in the maintenance of progenitors during development of a
number of different cell types in a variety of different organisms
(2, 3). Notch signals are essential for the development of
T lineage cells (4, 5, 6), whereas they prevent B cell
development (7, 8), suggesting that activation of Notch-1
signaling in multipotential hemopoietic progenitors controls T vs B
cell lineage determination. Washburn and colleagues (9)
have implicated Notch-1 signals in regulating the choice between the

vs 
T cell lineages during T cell development in the
thymus. Activated forms of Notch-1 also promote the survival and
maturation of DP thymocytes and influence the DP-SP transition
(10, 11, 12, 13). Collectively, these data indicate that Notch-1
may influence the survival and lineage commitment of T cell progenitors
at several discrete stages.
Notch activation in Drosophila is regulated by the temporal and spatial distribution of Notch ligands, Delta and Serrate, as well as by the expression of signaling modulators such as Numb (2). Experiments, primarily in Drosophila, indicate that Numb acts upstream of Notch action to inhibit Notch signaling (14, 15, 16, 17). For example, during the development of the sensory organ in Drosophila, loss-of-function mutations in dNumb mimic gain-of-function mutations in Notch, suggesting that Numb inhibits Notch activity (14). Numb may prevent the translocation of the Notch intracellular domain to the nucleus following ligand binding (15, 17). However, the direct effect of Numb on the expression of Notch target genes in vivo has not been reported.
The mechanisms regulating Notch activation in T cell progenitors are
not well defined. The Notch ligands, Jagged-1 and Jagged-2, are
expressed in the murine (18, 19) and rat (20)
thymus, and development of 
T cells is slightly impaired, but not
blocked in mice with a mutation in Jagged-2 (21).
Mammalian homologues of dNumb have been identified and are widely
expressed in embryos and in adult tissue, including the thymus
(22, 23, 24, 25). The function of mammalian Numb (mNumb) remains
unclear, but mNumb is thought to influence neurogenesis in vertebrates
(17, 22, 26). Mice with a null mutation in the mNumb gene
display multiple developmental defects involving the nervous system as
well as other cell lineages resulting in embryonic cell death before
day E11.5 (26, 27).
Structurally, mNumb resembles an adapter protein. It has an N-terminal phosphotyrosine-binding (PTB) domain (22, 23, 28), a proline-rich region containing several putative Src-homology 3 binding sites (23), and an Eps 15 homology domain-binding motif at the carboxyl terminus (29). Consistent with the notion that Numb acts as adapter protein, a number of mNumb-binding partners have been identified (29, 30, 31), including Notch-1 (22).
There are four different isoforms of mNumb (p65, p66, p71, and p72), which arise from alternative splicing of mNumb RNA, and are characterized by the presence or absence of an 11-aa insert in the PTB domain and the presence or absence of a 48-aa insert in the proline-rich region. All four isoforms of mNumb are expressed in the thymus, although the p65 and p66 isoforms are predominant (25, 32). This observation, together with the reports that dNumb inhibits Notch activity and that Notch-1 influences T cell development, prompted us to determine whether transgenic (Tg) overexpression of the p66 isoform of mNumb would antagonize Notch signaling in thymocytes and alter T cell development.
| Materials and Methods |
|---|
|
|
|---|
The complete coding sequence of rat Numb cDNA (nt 196-2007) (23) was cloned into the BamHI site of p1017, which contains the Lck proximal promoter and portions of the human growth hormone gene, including a polyadenylation sequence (33). In the resulting plasmid, the cDNA for Numb was flanked by the mouse Lck proximal promoter at the 5' end and portions of the human growth hormone gene, including introns and a polyadenylation sequence at the 3' end. The rat Numb cDNA that was used encodes the p66 mNumb isoform with the 11-aa insert in the PTB domain, but does not contain the 48-aa insert in the proline-rich region of the molecule (23). The amino acid sequence of the protein encoded is identical to the murine p66 isoform of Numb (25). A SpeI fragment from the plasmid consisting of the entire transgene was purified and injected into (C57BL/6 x SJL)F2 embyros. Tg+ founder mice were identified by PCR amplification of tail DNA using primers that spanned the junction between the Lck proximal promoter and mNumb (5' primer, ATG TCT CCC AGG TAG TCC CC and 3' primer, GTG CAT TCC TCT TGA CTC ATC). Tg+ founders were bred to C57BL/6. The majority of the analysis was performed on mice from two lines of founder mice that had been backcrossed three to four times to C57BL/6.
Immunoprecipitation, in vitro binding, and Western blotting
Protein extracts of thymus, spleen, and lymph nodes from
Tg+ and non-Tg (Tg-) mice
were made by homogenizing the tissues in lysis buffer (50 mM HEPES, 150
mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10 mM sodium
pyrophosphate, 100 mM NaF, 10% glycerol, 1% Triton X-100, and
protease inhibitors (Roche Molecular Biochemicals, Laval, Quebec,
Canada)). Lysates were centrifuged at 14,000 rpm at 4°C to
pellet insoluble matter. For each immunoprecipitation, 0.5 mg of
protein was made up to a volume of 0.5 ml with lysis buffer and
incubated for 24 h with Ab and protein A-Sepharose beads. Immune
complexes bound to protein A-Sepharose were washed four times with
lysis buffer and eluted by boiling in SDS sample buffer. Proteins were
separated by SDS-PAGE, transferred onto polyvinylidene difluoride
membrane (Immobilon-P), and immunoblotted with primary Ab for
12 h at room temperature. Bound Ab were visualized using
HRP-conjugated protein A, followed by ECL. mNumb was immunoprecipitated
using affinity-purified anti-Numb-A Ab and blotted with
anti-Numb-C Ab. Anti-Numb-A is specific for mNumb and does not
recognize the related protein, Numb-like (25). DN cells
from Tg+ and Tg- mice were
lysed in lysis buffer, and 50 µg of whole cell lysate was separated
by SDS-PAGE and analyzed by Western blot with Numb-C Ab. Blots were
reprobed with
-tubulin Ab (Amersham, Arlington Heights, IL) to
confirm equal protein loading.
Immunohistochemistry
Thymic tissue from Tg+ mice was rapidly removed, flash frozen to -80°C, and sectioned using a cryostat modular cryosection apparatus. The 5-µm thymic sections were mounted on positively charged slides (Fisher Scientific, Mississauga, Canada) and stored at -20°C. A dual immunofluorescent staining procedure was used to demonstrate Numb membrane colocalization with the AP-2 protein. Thymic sections were fixed via incubation at room temperature with 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO) for 30 min. Following the incubation, sections were washed three times for 15 min each with 1x PBS. To permeabilize the tissue, slides were incubated with a solution of 1x PBS containing 0.2% Triton X-100 at room temperature for 30 min. The slides were washed three times for 10 min each with 1x PBS. To prevent nonspecific binding of the secondary Ab used in the detection of Numb and AP-2, slides were incubated with a solution of 1x PBS containing 5% goat serum (The Jackson Laboratory, Bar Harbor, ME) at 37°C for 30 min. Slides were then washed as described above. To detect the Numb protein, slides were treated with a 1/10 dilution of a 1 mg/ml stock solution of rabbit anti-Numb polyclonal anti-Numb-C Ab (23) for 24 h at 4°C. The sections were washed three times for 10 min each and treated with a 1/300 dilution of a stock 2 mg/ml goat anti-rabbit Ab conjugated to AlexaFlour 488 (Molecular Probes, Eugene, OR) for 2 h at room temperature. Slides were washed and incubated with a 1/100 dilution of a stock 1 mg/ml mouse anti-AP-2 mAb (Affinity BioReagents, Golden, CO) for 24 h at 4°C. Slides were washed and treated with a 1/300 dilution of a stock 2 mg/ml goat anti-mouse Ab conjugated to CY3 (Molecular Probes) for 2 h at room temperature. Slides were coverslipped (Baxter Diagnostics, McGraw Park, IL) with fluorescent mounting media (DAKO Diagnostics, Carpinteria, CA) and analyzed using a confocal microscope.
RT-PCR analysis of endogenous Numb, Tg Numb, and Notch-1 target genes in Tg- and Tg+ thymus
RNA from thymi from Tg+ and Tg-littermates that were 3- to 4-wk-old was prepared
using the TRIzol system (Life Technologies, Grand Island, NY).
Superscript II reverse transcriptase (Invitrogen, San Diego, CA) was
used to prepare cDNA, which was then normalized for equivalent template
amounts by serial dilution and amplification using primers specific to
-actin (5'-GTCGTACCACAGGCATTGTGATGG-3' and
5'-GGTGGTACATGGGTCCGTAACG-3'). RT-PCR analysis was conducted as
described previously (11). Briefly, normalized cDNA
amplified for 35 cycles (95°C, 1 min; 60°C, 30 s; 72°C, 1
min) using primers specific for all isoforms of endogenous mNumb
(5'-CTACGGCAAAGCTTCAGGAGA-3' and 5'-TCAGCAACTTTTCACTAATCC-3') and Tg
mNumb (5'-AGAAGTGTCAAAGAGTGTGCG-3' and 5'-CAG
GCTTTTTGACAACGCTAT-3'). To analyze specific Notch-1 target
genes, normalized cDNA was serially diluted 3-fold and amplified
for 3560 cycles (95°C, 1 min; 55°C, 1 min; 72°C, 1 min) using
Ifi-D3 (5'-ACTTCCTCTGTGTTAGAGGCTGC-3' and
5'-AAAGCTGTCATTTAGAGGTG-3'), Hes-1 (5'-GCCAGTGTCAACACGACACCGG-3'
and 5'-TCACCTCGTTCATGCACTCG-3'), and preT
(5'-TGGCTGCAACTGGGTCATGCTTC-3' and 5'-GGCTCAGAGGGGTGGGTAAGATC-3')
primers. PCR products were separated by electrophoresis through a 0.8%
agarose gel.
Abs and flow cytometry
Single-cell suspensions were prepared from thymus, spleen,
lymph node, and bone marrow; stained (2 x
106 cells/sample) with various Ab; and analyzed
by flow cytometry. The following mAb, which were generated in the
laboratory unless otherwise indicated, were used: anti-CD4 PE;
anti-CD4 FITC (GK1.5); anti-CD4 biotin (YTS191.1); anti-CD8
APC; anti-CD8 FITC (53-6.7); anti-CD8 biotin (YTS169.4);
anti-B220 FITC (6B2); anti-B220 biotin; anti-B220 APC (Cedarlane,
Hornby, Ontario, Canada); anti-CD3
biotin (YCD3); anti-TCR
FITC; anti-TCR
biotin (H57-597); anti-TCR 
biotin (GL3; BD
PharMingen, San Diego, CA); anti-CD25 FITC (7D4; BD PharMingen);
anti-CD44 PE (IM781); and anti-IgM FITC (R6-60.2; BD
PharMingen). Biotinylated Ab were detected either with streptavidin-PE
or streptavidin-Cy5PE. Where required, Ab directed against
CD45.1 and/or CD45.2 (FITC or PE conjugated; BD PharMingen) were
included. All FACS analysis was performed on a FACSCalibur flow
cytometer with CellQuest software (BD Biosciences, Mountain View, CA).
Dead cells were excluded by gating for forward scatter and propidium
iodide (PI) exclusion. For each sample, 50,000125,000 cells were
analyzed. Cell cycle analysis was performed by PI staining of
ethanol-fixed, RNase-treated cells, followed by flow cytometric
analysis of DNA content, as previously described (34).
Purification of DN2/3 thymocytes and peripheral T cells
DN2/3 thymocytes from Tg+ and Tg- mice were isolated and purified as follows. Thymocytes expressing CD4, CD8, and/or CD3 surface receptors were removed using purified Abs directed against CD4, CD8, and CD3, and sheep anti-rat IgG magnetic beads (Dynal, Great Neck, NY). CD44+CD25+ (DN2) and CD44-CD25+ (DN3) cells were then isolated (99% pure) by cell sorting. Peripheral lymph node cells were enriched for T cells (peripheral T cells) by magnetic bead depletion of cells that express B220, Mac-1, and Gr-1 cell surface receptors.
Generation of mixed bone marrow chimeras
Mixed bone marrow chimeras were generated using an adaptation of the engraftment model (35). T cell-depleted bone marrow was prepared from Ly-5.2+ mNumb Tg+ or Tg- littermates and Ly-5.1+ C57BL/6 mice (B6.SJL-ptprca/BoAiTac; Taconic Farms, Germantown, NY). T cells were depleted from bone marrow by magnetic depletion of Thy-1.2-expressing cells. A total of 5 x 106 cells was injected i.v. into RAG-2-/- mice (B10.D2/nSnJTac-Rag2tm1 N10; Taconic Farms) that had been gamma-irradiated with a lethal dose (1000 cGy, Gammacell 137C source; Atomic Energy, Ottawa, Canada) 418 h before injection. Chimeras were analyzed 45 wk following reconstitution.
Cell culture
Thymocytes (3 x 106 cells/ml) from Tg+ or Tg- mice were cultured in RPMI 1640 supplemented with 12.5% FBS, 25 mM HEPES (pH 7), 50 µM 2-ME, and 2 mM L-glutamine for 24 or 40 h. Cell cycle analysis and the degree of apoptosis were determined by FACS analysis of the DNA content, as described above.
| Results |
|---|
|
|
|---|

vs 
TCR+ T cell
and CD4+ vs CD8+ T cell
development. Four lines of Tg mice were generated. Most of the
experiments were done using the two founder lines, A and B, which had
the highest levels of thymic mNumb expression. Similar results were
obtained with each line; therefore, the results have been combined.
Immunoprecipitation and Western blot experiments demonstrated that
mNumb protein was dramatically overexpressed in thymocytes (Fig. 1
A). This was evident at the
early DN stage of thymic development, since Numb was detected by
Western blot in Tg+ DN, but not in
Tg- DN cells (Fig. 1
B). mNumb was
also elevated in the spleen and lymph node cells of
Tg+ mice in comparison with their
Tg- littermates (Fig. 1
A). Using
anti-Numb antisera recognizing different regions of the Numb
protein, we confirmed that the transgenically expressed mNumb protein
is full length (data not shown). Confocal microscopy revealed that Tg
mNumb was localized to thymic cell membranes and colocalized with AP-2,
a marker of clathrin-coated pits and early endosomes (Fig. 1
, CE). This is in agreement with previous studies showing
that mNumb proteins interact with components of the early endocytic
machinery and localize to endocytic vesicles (37) (S.
E. Dho, C. A. Smith, and C. J. McGlade, manuscript in
preparation). To further examine the timing of Tg mNumb and endogenous
mNumb expression during thymocyte development, we performed RT-PCR on
RNA extracted from DN2/3 and DP subpopulations of thymocytes and from
mature peripheral T cells isolated from 4-wk-old mice. Two primer
pairs, one specific for endogenous mNumb and the other specific for Tg
mNumb, were used in the reaction. Both endogenous mNumb and Tg mNumb
mRNA was detected in all of the subpopulations of cells (Fig. 1
F). Therefore, Tg mNumb protein was expressed during
thymocyte development before
- and
-chain rearrangement and
before CD4/CD8 lineage commitment, and it localized correctly within
the cells.
|
, and Ifi-D3, which have previously been
shown to be up-regulated in the presence of constitutively active
Notch-1 (11). Total RNA from Tg+ or
Tg- littermates was isolated and used in
semiquantitative PCR. The expression of all three of these genes was
reduced in the Tg thymi as compared with controls (Fig. 2
was also reduced in thymocytes from 5-wk-old Tg+
mice compared with Tg- littermates (data not
shown). To further delineate the developmental stages at which Notch-1
signaling was decreased by Tg Numb, we examined the expression of
Ifi-D3 by semiquantitative RT-PCR of RNA prepared from
sorted populations of DN2/3 and DP thymocytes and peripheral T cells.
Ifi-D3 expression was significantly decreased in
Tg+ cells in comparison with
Tg- cells in all subpopulations (Fig. 2
|
(A), and
immature DN thymocytes stained for CD44, CD25, and B220 (B),
and indicates the similar percentages of cells positive for these
surface markers in Tg+ vs
Tg- mice. There was no increased generation of
intrathymic B cells in Tg+ mice, an observation
that has been made in mice with conditional inactivation of Notch-1 in
bone marrow precursors (4), and in mice overexpressing
Lunatic Fringe, a negative regulator of Notch-1 signaling, in cells
before T/B lineage commitment (6). Fig. 4
TCR+ thymocytes; B220+,
IgM+, and 
TCR+
splenocytes; and 
TCR+ and 
TCR+ lymphocytes. The proportions of cells in
these different lineages were similar when the results from
Tg+ and Tg- mice were
compared (data not shown). In addition, the total number of cells in
the thymus, spleen, and lymph nodes of Tg+ and
Tg- littermates was similar (Table I
/
or CD4/CD8 lineage commitment.
|
|
|
|

T cells derived from progenitors with reduced
levels of Notch-1 (9). Using a similar strategy, bone
marrow cells from Ly-5.2+ mNumb
Tg+ or Tg- littermates and
Ly-5.1+ wild-type mice were mixed in a 1:1 ratio,
injected into irradiated RAG-2-/-
recipients, and analyzed at day 35 or 43. Based on previous studies, we
expected that there would be an increase in the contribution of mNumb
Tg+ cells to the 
T cell lineage and/or a
decrease in the contribution of mNumb Tg+ cells
to the CD8+ T cell lineage in the presence of
mNumb inhibition of Notch-1 activity.
The percentages of Tg+ or
Tg- cells contributing to the thymus, spleen,
and lymph nodes were similar in recipient mice that received mixtures
of Tg+ and wild-type
Ly-5.1+ bone marrow or those that received
control mixtures of Tg- and wild-type
Ly-5.1+ bone marrow (Table II
). In addition, the proportions of
Tg+ and wild-type Ly-5.1+
cells contributing to DN, DP, CD4+, and
CD8+ SP and 
TCR+
subsets in these tissues were similar. There was a small increase in
the proportion of Tg+ B cells
(B220+) and a small decrease in the proportion of
Tg+ T cells (CD4+ SP or
CD8+ SP) in the spleen and lymph nodes of the
recipient mice reconstituted with mixtures of Tg+
and wild-type Ly-5.1+ bone marrow cells (Fig. 6
). However, these differences were also
observed in the control recipients that were injected with mixtures of
Tg- and wild-type Ly-5.1+
cells. Therefore, it is unlikely that these differences reflect an
effect of Tg mNumb overexpression.
|
|

, 
, DP, and SP production from
Tg+ vs Tg- bone marrow
cells.
In previous work by others, Tg expression of a constitutively active
form of Notch-1 also promoted survival of thymocytes in culture
(10). Therefore, we determined whether thymocytes with Tg
overexpression of mNumb would undergo apoptosis more readily in
culture. We observed similar amounts of cell death in cultures of
Tg+ and Tg- thymocytes
(Table III
), suggesting the Tg mNumb does
not increase apoptosis in vitro.
|
| Discussion |
|---|
|
|
|---|
We analyzed two different lines of Tg mice to determine the effect of
mNumb overexpression on endogenous Notch-1 activity and on T cell
development. High levels of functional p66 mNumb protein were expressed
in thymocytes of Tg mice, including DN cells. Overexpression of mNumb
resulted in reduced expression of three genes, Hes-1,
preT
, and Ifi-D3, previously shown to be
up-regulated by activated Notch (11), providing evidence
that Numb antagonizes endogenous Notch-1 signaling. This reduction was
evident as early as the DN2/3 stage of development coincident with
commitment to the T cell lineage. Despite this evidence for a
direct effect of Numb on Notch-1 signaling, we were unable to
detect any changes in 
/
or CD4/CD8 lineage commitment or
thymocyte cell cycle or survival. Moreover, the lymphopoietic activity
of bone marrow from mNumb Tg+ mice was equivalent
to that of Tg- bone marrrow in competitive
repopulation experiments.
In support of our results, it was recently reported that Notch-1
signaling is not required after T cell commitment for thymocyte
survival, differentiation, or fate specification in mice with a
conditional, loss-of-function mutation of Notch-1
(43). There is the possibility that other Notch genes may
have acted redundantly in place of Notch-1 in that study, since
downstream consequences of the conditional Notch-1 deletion
were not directly measured (43). However, results from our
analyses of Numb Tg+ mice, in which Notch
signaling is down-regulated through Numb overexpression, support the
conclusion that Notch-1 signaling is not required in thymocytes for

/
or CD4/CD8 fate specification.
In contrast, previous studies on the role of Notch-1 signaling in T
cell development, in which a truncated, constitutively active form of
Notch-1 was overexpressed in thymocytes, led to the conclusion that
Notch-1 signaling plays a critical role in 
/
and CD4/CD8
lineage decisions during T cell development (12, 13). This
form of Notch is known to be oncogenic in several cell types, including
T cells, and may have produced a nonphysiologic effect
(44, 45, 46). It is also possible that activated Notch-1 may
have altered the activity or expression of proteins that are normally
influenced by other Notch genes. The role of these other Notch family
members was not addressed in experiments in which Notch-1
was constitutively deleted (43), and the effect of mNumb
on the activity of other Notch genes is not known.
Reduction of Notch-1 levels in bone marrow cells results in an
enhancement in the development of 
TCR+ T
cells, which can be observed in competitive reconstitution experiments
with mixtures of Notch-1 heterozygous mutant and normal bone marrow
(9). We used a similar strategy to study the effect of Tg
overexpression of mNumb on the 
TCR vs 
TCR lineage
commitment. Transgenic mNumb was readily expressed in DN2/3 thymocytes,
and the expression of the Notch target gene, Ifi-D3, was
significantly reduced in this subpopulation. Thus, an effect of mNumb
on 


lineage commitment, if present, should have been
observed at this developmental stage; however, we found that mNumb
Tg+ and Tg- cells
contributed equally to the different cell lineages in repopulation
experiments at the different time points analyzed. Therefore, Tg
overexpression of mNumb and down-regulation of Notch signaling at this
stage of development do not mimic the effect of reduced Notch-1 levels
in competitive repopulation experiments. It is possible that the
inhibition of Notch by Numb overexpression in our experiments was
insufficient or perhaps the reduction in Notch-1 may be required
earlier, since in the experiments with heterozygous Notch-1 mutants
(9), Notch-1 expression would be reduced at all stages of
development.
In mammals, there are four isoforms of mNumb, and several lines of evidence imply that the Numb isoforms may have distinct cellular functions (25, 32). It is currently unknown whether the Numb isoforms differ in their capacity to antagonize Notch-1, or whether they interact with other Notch family members. In this study, we have shown that the p66 isoform of Numb is able to suppress expression of Notch-1 target genes in vivo. We cannot exclude the possibility that a different isoform of Numb may have a different effect on Notch-1 signaling or on other Notch genes expressed in the thymus, which would alter T cell development. However, we are aware of unpublished results in which the p65 isoform of mNumb was transgenically expressed using the same promoter, and like our results, no alterations in T cell development were observed (Y.-R. Zou and D. R. Littman, personal communication).
Conditional targeting of Notch-1 much earlier in development
has revealed an essential role in specification of T vs B lineage
precursors (4, 7, 8). Therefore, during the course of
lymphocyte development, there is an apparent transition between Notch-1
dependence and independence. As such, a role for Numb in lymphocyte
development will likely be revealed by modulating its levels at earlier
stages of hemopoiesis. Our results, in keeping with recently published
work (43), support the conclusion that in immature
thymocytes, Notch-1 signaling is not essential for 
/
or
CD4/CD8 T cell lineage commitment or survival.
| Footnotes |
|---|
2 M.B.F. and U.K. contributed equally to this work. ![]()
3 Address correspondence and reprint requests to Dr. C. Jane McGlade, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada, M5G 1X8. E-mail address: jmcglade{at}sickkids.on.ca ![]()
4 Abbreviations used in this paper: DN, double negative; dNumb, Drosophila numb; DP, double positive; mNumb, mammalian Numb; PI, propidium iodide; PTB, phosphotyrosine binding; SP, single positive; Tg, transgenic. ![]()
Received for publication May 11, 2001. Accepted for publication January 22, 2002.
| References |
|---|
|
|
|---|

versus 
T cell lineage decision. Cell 88:833.[Medline]
This article has been cited by other articles:
![]() |
K. Laky and B.J. Fowlkes Presenilins regulate {alpha}{beta} T cell development by modulating TCR signaling J. Exp. Med., September 3, 2007; 204(9): 2115 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wilson, D.-L. Ardiet, C. Saner, N. Vilain, F. Beermann, M. Aguet, H. R. MacDonald, and O. Zilian Normal Hemopoiesis and Lymphopoiesis in the Combined Absence of Numb and Numblike J. Immunol., June 1, 2007; 178(11): 6746 - 6751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van den Brandt, S.-H. Kwon, T. Hunig, K. G. McPherson, and H. M. Reichardt Sustained Pre-TCR Expression in Notch1IC-Transgenic Rats Impairs T Cell Maturation and Selection J. Immunol., June 15, 2005; 174(12): 7845 - 7852. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Huang, H. Li, A. A. Tang, A. K. Wiggins, R. L. Neve, W. Zhong, L. Y. Jan, and Y. N. Jan Targeted deletion of numb and numblike in sensory neurons reveals their essential functions in axon arborization Genes & Dev., January 1, 2005; 19(1): 138 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hoflinger, K. Kesavan, M. Fuxa, C. Hutter, B. Heavey, F. Radtke, and M. Busslinger Analysis of Notch1 Function by In Vitro T Cell Differentiation of Pax5 Mutant Lymphoid Progenitors J. Immunol., September 15, 2004; 173(6): 3935 - 3944. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Smith, S. E. Dho, J. Donaldson, U. Tepass, and C. J. McGlade The Cell Fate Determinant Numb Interacts with EHD/Rme-1 Family Proteins and Has a Role in Endocytic Recycling Mol. Biol. Cell, August 1, 2004; 15(8): 3698 - 3708. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cayouette and M. Raff The orientation of cell division influences cell-fate choice in the developing mammalian retina Development, June 1, 2003; 130(11): 2329 - 2339. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||